🐜
|
TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
16 auth.
U. Tabori,
A. Shlien,
B. Baskin,
S. Levitt,
P. Ray,
N. Alon,
C. Hawkins,
E. Bouffet,
M. Pienkowska,
L. Lafay-Cousin,
...
Alexa Gozali,
N. Zhukova,
L. Shane,
I. González,
J. Finlay,
D. Malkin
|
7 |
2010 |
7 🐜
|